• TOC-COVID Trial • Prospective placebo controlled RCT
• N = 100 tocilizumab + standard treatment
•  N = 100 placebo + standard treatment
• Primary outcome of ventilation-free days • Tocilizumab 8 mg/kg single i.v. dose (Rilinger et al., 2020)